| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Sage Therapeutics, Inc. | Chief Scientific Officer and Interim Head of R&D | Common Stock | 0 | $0 | $7.79 | Jul 31, 2025 | Direct |
| Sage Therapeutics, Inc. | Chief Scientific Officer and Interim Head of R&D | S | 4K | Apr 1, 2025 | Direct | ||
| Sage Therapeutics, Inc. | Chief Scientific Officer and Interim Head of R&D | Stock Option (Right to Buy) | 0 | Jul 31, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SAGE | Sage Therapeutics, Inc. | Jul 31, 2025 | 4 | $0 | 4 | Jul 31, 2025 | Chief Scientific Officer and Interim Head of R&D |
| SAGE | Sage Therapeutics, Inc. | Jun 24, 2025 | 1 | -$1.04K | 4 | Jun 26, 2025 | Chief Scientific Officer and Interim Head of R&D |
| SAGE | Sage Therapeutics, Inc. | Apr 10, 2025 | 4 | -$5.09K | 4 | Apr 11, 2025 | Chief Scientific Officer and Interim Head of R&D |
| SAGE | Sage Therapeutics, Inc. | Apr 1, 2025 | 2 | $0 | 4 | Apr 2, 2025 | Chief Scientific Officer and Interim Head of R&D |
| SAGE | Sage Therapeutics, Inc. | Apr 1, 2025 | 0 | $0 | 3 | Apr 2, 2025 | Chief Scientific Officer and Interim Head of R&D |